Evidence map›Paper›PMID 37138757›Full record

ArticleFrontiers in medicine2023

Case report: Severe pneumonia and pneumomediastinum in a previously robust adolescent caused by Omicron BA.5.2.

Tianxin Xiang, Jianhua Fang, Tao Cheng, Zhongmin Li, Daxian Wu, Shouhua Zhang, Shanfei Ge, Wei Zhang

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Tianxin Xiang *Department of Hospital Infection Control, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Jianhua Fang *Department of Infectious Disease, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Tao ChengDepartment of Respiratory Medicine, The Second People's Hospital of Shangrao, Shangrao, China.
Zhongmin LiDepartment of Infectious Disease, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Daxian WuDepartment of Infectious Disease, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Shouhua ZhangDepartment of General Surgery, Jiangxi Provincial Children's Hospital, Nanchang, China.
Shanfei GeDepartment of Infectious Disease, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Wei ZhangThe Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China.
First Affiliated Hospital of Nanchang University · CNNanchang University · CNJiangxi Provincial Children's Hospital · CNSecond Hospital of Nanchang · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The manifestation of severe pneumonia is only occasional, and pneumomediastinum is a condition that occurs rarely in Coronavirus disease 2019 (COVID-19) patients, especially in those patients who are infected with the Omicron variant. In addition, whether severe pneumonia or pneumomediastinum often occurs in patients in older age, in poor physical condition, or with underlying diseases remains to be ascertained. To date, severe pneumonia and pneumomediastinum due to Omicron infection had not been reported in a young patient with an excellent physical condition. In this study, we report such a case with the aforementioned manifestations in a robust adolescent infected with Omicron BA.5.2.

Indexed as

adolescentCOVID-19mediastinal emphysemaOmicronsevere pneumonia

Identifiers

PMID37138757
PMCPMC10149875
OpenAlexW4366225007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.